Joined October 2018
Pro #Football Hall of Fame #trademark and media works #licensing agreement for Hall of Fame Village use includes $0.6 - $0.9M annual fees and a 10% royalty of net profit to non-Village opportunities. #copyright #sports buff.ly/3JKyNv9
#Licensing agreement to market, sell and distribute #hypertension drug in Israel includes payments of up to $11 M and sales-based royalties of 25% to 30%. #cardiovascular #biopharma #bloodpressure #brainhealth buff.ly/37Pr1Tq
Topps #baseball card deal with #MLB ends after 70 yrs. Before the player association group #NIL #licensing, players got a $75 advance and $500 a year. buff.ly/37kX7GL View recent MLB deal royalty payments. buff.ly/3syexpr #sports
#Licensing agreement and option to multisystem inflammatory syndrome #IntellectualProperty includes stock purchase, upfront, milestone and sales-based low-single digit royalty payments. #pediatric #MISC #biopharma buff.ly/36jicRy
Amended #licensing agreement to develop #cardiorenal disease treatments increased upfront payments and lowered sales-based royalty rates from high teens to low double to mid-single digits. #kidney #Heartdisease buff.ly/37H9VqN
Global #telecom API market to grow annually 20.6% 2022-28. API software bridges networks and devices to meet technology trends such as migration to #cloud platforms and access to #digitalservices. #marketshare buff.ly/3O1KHnC
Collaboration agreement, with #licensing option, to develop #genetherapy proteins targeting #rarediseases includes upfront, research, milestone and tiered sales-based royalty payments. #biopharma buff.ly/3DWF1qo
#Namingrights deal benefits expand to #localcommunity #recreation area with proposed 7 year $17,500 annual payment. buff.ly/3vppOKT View more deal transactions at buff.ly/3rjaXyM #sports #football
Agreement to develop interferon alpha compound-based #cancer treatments include upfront, milestone and tiered mid-single-digit sales-based royalty payments. #immunooncology #biopharma #licensing buff.ly/3rdtIVA
#Licensing agreement to develop treatments for a broad-spectrum of #antibiotic activity includes a share purchase and milestone and high single- to low double-digit sales-based royalty payments. #biopharma #superbugs buff.ly/37rQqlW
#Licensing option exercised to develop an antibody targeting an immune- #oncology target includes research funding, and upfront, milestone and sales-based single to double digit royalty payments. #cancer #immunotherapy buff.ly/3u365kp
#Licening agreement to next-gen CDK9 inhibitors for a broad range of #cancer indications includes upfront, milestone and low to high single digit sales-based royalty payments. #biopharma buff.ly/3uMs52o
#Licensing agreement to continue #myeloma and non- #Hodgkins #lymphoma therapeutics development includes milestone and sales based low-single digit royalty payments. #cancer #biopharma buff.ly/3K5yM5Q
#Licensing agreement to use #patent and know-how to develop a #vaccine designed to target #respiratory #virus includes upfront, milestones and fixed low single digit sales-based royalty payments. #biopharma #pneumonia buff.ly/3K2ExkJ
#Licensing agreement to use #patent and know-how to develop #influenza #virus #vaccine includes upfront, milestones and fixed low single digit sales-based royalty payments. #biopharma buff.ly/3DAPibS
Flexible #electronics market to grow annually at nearly 21% 2022-2028. #Automotive, consumer electronics, #defense, and #healthcare sectors to drive demand for flexible circuits. #marketsize #markegrowth #licensing buff.ly/37Xu7ER
#Licensing option to #virus capsids generated for use with undisclosed central nervous system targets includes upfront, option, milestone and sales based mid- to high-single-digit royalty payments. #genetherapy #neurology buff.ly/3wFP15W
#Licensing and supply agreement to develop a #vaccine for the prevention of #respiratory syncytial #virus includes upfront, milestone and sales-based tiered double-digit royalty payments. buff.ly/36rAFLQ
Evaluation #licensing agreement to investigate #patent to #lithium recovery extraction process from natural #brine. buff.ly/3Ddtoek Insight into other lithium/ #battery technology licenses summarized at buff.ly/3DhWcma
Annual #licensing revenue reported for college athlete's endorsement may range from $1,000 – $40,000. Professionals from $50,000 – $400,000 for the same target group of licenses. #sports #intellectualproperty #NIL buff.ly/3aYt98a